|Articles|July 2, 2021
This Week in Aesthetics: June 28 – July 2
Author(s)Katie Hobbins
This week in aesthetics, we highlight the FDA approval of Restylane Contour, a guide to Aesthetics Biomedical’s upcoming “The Evolution of Aesthetics” symposium, and more.
Advertisement
This week in aesthetics, Advanced Aesthetic Technologies announces the start of the Algeness VL clinical trial in China, Galderma receives Restylane Contour FDA approval for cheek augmentation, we give a guide to Aesthetics Biomedical’s upcoming “The Evolution of Aesthetics” symposium, and a study compares the results of single-plane vs double-plane MFU-V for upper arm skin laxity.
Advanced Aesthetic Technologies, Inc, announces start of Algeness VL clinical trial in China seeking future market approval.
Galderma receives Restylane Contour FDA approval for cheek augmentation and correction of midface contour deficiencies.
With in-person conferences coming out of the shadows and into the light once again, we detail a guide to Aesthetics Biomedical’s “Perspectives. The Evolution of Aesthetics” symposium happening July 24.
A study compared the results of single-plane vs double-plane MFU-V for upper arm skin laxity treatment.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
4
Dermatology Conferences and Meetings Calendar: December 2025
5
